Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure and Function of Platelets01:18

Structure and Function of Platelets

1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

5.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.5K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

505
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
505
Disorders of Hemostasis01:24

Disorders of Hemostasis

781
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
781
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

659
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
659

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Nanomaterial toxicity and risk assessment integrating functionalization strategies advanced in vitro models and regulatory perspectives.

Discover nano·2026
Same author

Selective Anticancer Activity and Safety Profile of Chlorochalcones: Impact on Breast Cancer, Blood, and Endothelial Cells.

Cells·2025
Same author

Advanced Strategies in Enhancing the Hepatoprotective Efficacy of Natural Products: Integrating Nanotechnology, Genomics, and Mechanistic Insights.

ACS biomaterials science & engineering·2025
Same author

Insights on the Mechanisms of the Protective Action of Naringenin, Naringin and Naringin Dihydrochalcone on Blood Cells in Terms of Their Potential Anti-Atherosclerotic Activity.

Molecules (Basel, Switzerland)·2025
Same author

Biphasic dose-response and effects of near-infrared photobiomodulation on erythrocytes susceptibility to oxidative stress in vitro.

Journal of photochemistry and photobiology. B, Biology·2024
Same author

Changes in the blood redox status of horses subjected to combat training.

Research in veterinary science·2024

相关实验视频

Updated: Jun 19, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

829

血小板存储 - - 问题,改进和新视角

Natalia Trochanowska-Pauk1, Tomasz Walski2, Raghvendra Bohara3

  • 1Department of Physics and Biophysics, The Faculty of Biotechnology and Food Science, Wrocław University of Environmental and Life Sciences, 50-375 Wrocław, Poland.

International journal of molecular sciences
|July 27, 2024
PubMed
概括

血小板储存损伤限制了输血的可用性. 对存储条件,解决方案,测试和数据建模的研究旨在改善血小板质量并延长关键患者的保质期.

关键词:
血液银行 血液银行血小板缩剂 血小板缩剂血小板的存储是血小板的存储.血小板储存损伤 血小板的损伤货架寿命 货架寿命

更多相关视频

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

9.4K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.8K

相关实验视频

Last Updated: Jun 19, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

829
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

9.4K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.8K

科学领域:

  • 输血医学 输血医学
  • 生物技术是生物技术.
  • 生物物理学的生物物理.

背景情况:

  • 血小板输血对于预防重症患者出血至关重要.
  • 由于存储损伤和细菌污染风险,血小板的保质期很短 (5 天).
  • 血小板储存损伤 (PSLs) 会导致身体和功能退化.

研究的目的:

  • 分类和审查与血小板储存病变 (PSLs) 相关的挑战.
  • 探索血小板存储的潜在改进和新的视角.
  • 提供关于PSL缓解当前研究领域的全面概述.

主要方法:

  • 将PSL研究分为四个主要领域:储存条件,添加剂解决方案,先进的血小板测试 (蛋白质组学,代谢组学) 和数据建模 (数学,统计学,人工智能).
  • 文献综述和对PSL当前知识的综合.
  • 分析不同研究领域的挑战和潜在解决方案.

主要成果:

  • PSLs是多方面的,受到储存环境,溶液和固有的血小板性质的影响.
  • 蛋白质组和代谢组分析为评估血小板质量提供了新的途径.
  • 数据建模,包括人工智能,显示出优化血小板生产和库存管理的前景.
  • 添加剂解决方案和优化的储存条件可以减轻某些PSL方面.

结论:

  • 解决PSL需要采用多学科方法,结合改进的存储,新型测试和先进的数据分析.
  • 进一步研究添加剂解决方案和实时质量监测至关重要.
  • 通过科学创新优化血小板的可用性和质量对于患者的护理至关重要.